Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 110 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $145,258 | -24.2% | 26,653 | -5.6% | 0.00% | – |
| Q2 2023 | $191,653 | +223.9% | 28,226 | +139.0% | 0.00% | – |
| Q1 2023 | $59,177 | +1386.1% | 11,812 | +1347.5% | 0.00% | – |
| Q4 2022 | $3,982 | -63.8% | 816 | 0.0% | 0.00% | – |
| Q3 2022 | $11,000 | -98.9% | 816 | -98.7% | 0.00% | -100.0% |
| Q4 2021 | $1,043,000 | +0.8% | 64,404 | +77.5% | 0.00% | 0.0% |
| Q3 2021 | $1,035,000 | +935.0% | 36,280 | +1119.1% | 0.00% | – |
| Q2 2021 | $100,000 | +12.4% | 2,976 | 0.0% | 0.00% | – |
| Q1 2021 | $89,000 | -41.1% | 2,976 | -24.7% | 0.00% | – |
| Q3 2020 | $151,000 | -11.2% | 3,953 | 0.0% | 0.00% | – |
| Q2 2020 | $170,000 | – | 3,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $932,939 | 3.08% |
| Sofinnova Investments, Inc. | 2,194,278 | $10,708,077 | 0.64% |
| Artal Group S.A. | 400,000 | $1,952 | 0.11% |
| Polar Capital Holdings Plc | 1,991,929 | $9,720,614 | 0.08% |
| ASHFORD CAPITAL MANAGEMENT INC | 98,870 | $482,486 | 0.08% |
| Soleus Capital Management, L.P. | 87,182 | $425,448 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 99,160 | $484 | 0.06% |
| Cormorant Asset Management, LP | 150,000 | $732 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 48,233 | $235,377 | 0.04% |
| XTX Topco Ltd | 38,574 | $188,241 | 0.04% |